+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Can disease activity in patients with psoriatic arthritis be adequately assessed by a modified Disease Activity index for PSoriatic Arthritis (DAPSA) based on 28 joints?



Can disease activity in patients with psoriatic arthritis be adequately assessed by a modified Disease Activity index for PSoriatic Arthritis (DAPSA) based on 28 joints?



Annals of the Rheumatic Diseases 77(12): 1736-1741



To test the psychometric performance of a modified Disease Activity index for PSoriatic Arthritis (DAPSA) using 28 instead of 66 swollen/68 tender joint counts (SJC/TJC). We included patients with psoriatic arthritis (PsA) from the Danish national quality registry DANBIO, divided into examination (n=3157 patients, 23987 visits) and validation cohorts (n=3154 patients, 24160 visits). We defined DAPSA28 = (28TJC × conversion factor1) + (28SJC × conversion factor2) + patient global (0-10VAS) + pain (0-10VAS) + C reactive protein (CRP) (mg/dL). Identification of the conversion factors was performed by generalised estimating equations in the examination cohort and evaluation of criterion, correlational and construct validity in the validation cohort. We estimated DAPSA28 = (28TJC × 1.6) + (28SJC × 1.6) + patient global (0-10VAS) + pain (0-10VAS) + CRP (mg/dL). Criterion validity: DAPSA/DAPSA28 had comparable discriminative power expressed as standardised mean difference (DAPSA, 0.90; DAPSA28, 0.93) to distinguish between patients in high and low disease activity. Kappa with quadratic weighting of DAPSA/DAPSA28 disease activity states was high: 0.92 (95% CI 0.92 to 0.92). Standardised response means for DAPSA/DAPSA28 were -0.96/-0.92 for visits after biological DMARD-initiation. Correlational validity: Baseline DAPSA/DAPSA28 had high correlation with 28-joint disease activity score with CRP (r=0.87/r=0.93), simplified disease activity index (r=0.92/r=0.99), p<0.001. Bland-Altman plot showed better agreement between DAPSA/DAPSA28 for low than high disease activity. Construct validity: DAPSA/DAPSA28 were similarly correlated to Health Assessment Questionnaire; r=0.60/0.62, p<0.001. DAPSA/DAPSA28 discriminated patients reporting their symptom state as acceptable versus not acceptable equally well: mean (SD) 9.1 (8.7)/8.4 (8.0) and 24.2 (14.9)/22.5 (13.8), respectively. Our study suggests that data sets with only 28-joint counts available can be used to calculate DAPSA28, especially in patients with low disease activity. DAPSA28 showed good criterion, correlational and construct validity and sensitivity to change. Still, our results support that 66/68 joint count should be performed and the original DAPSA should be preferred in PsA.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065717551

Download citation: RISBibTeXText

PMID: 30237203

DOI: 10.1136/annrheumdis-2018-213463


Related references

AB0930DAREA/DAPSA (disease activity score for reactive arthritis/disease activity index for psoriatic arthritis) and related variables in patients with psoriatic arthritis (PSA):. Annals of the Rheumatic Diseases 71(Suppl 3): 691.18-691, 2013

Disease activity and response assessment in psoriatic arthritis using the Disease Activity index for PSoriatic Arthritis (DAPSA). A brief review. Clinical and Experimental Rheumatology 33(5 Suppl 93): S48, 2015

SAT0403Further Analysis of Psoriatic Arthritis Disease Activity Score (PASDAS) and Composite Psoriatic Disease Activity Index (CPDAI) Using Data from A Placebo-Controlled TRIAL of Certolizumab Pegol in Psoriatic Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 740.1-740, 2014

SAT0398Application of Disease Activity Index for Psoriatic Arthritis (DAPSA) in A Cohort of Patients Followed in The Institute of Rheumatology Prague. Annals of the Rheumatic Diseases 75(Suppl 2): 813.2-813, 2016

Burden of Psoriatic Arthritis According to Different Definitions of Disease Activity: Comparing Minimal Disease Activity and the Disease Activity Index for Psoriatic Arthritis. Arthritis Care and Research 70(12): 1764-1770, 2018

FRI0469Measuring Outcome in Psoriatic Arthritis (MOPSA), A New Web-Based Tool for Assessment of Psoriatic Arthritis Showing Initiation of Treatment Change in Patients Achieving Minimal Disease Activity. Annals of the Rheumatic Diseases 75(Suppl 2): 607.2-607, 2016

Development of a disease activity and responder index for psoriatic arthritis--report of the Psoriatic Arthritis Module at OMERACT 11. Journal of Rheumatology 41(4): 782-791, 2014

Gender does not make a difference in "composite psoriatic disease activity index (CPDAI)" in patients with psoriatic arthritis. Rheumatology International 38(11): 2069-2076, 2018

The Assessment of Disease Activity in Psoriatic Arthritis: Mda, Vlda, Dapsa, or Something Else?. The Journal of Rheumatology 46(7): 663-664, 2019

The Disease Activity Score in 28 joints in rheumatoid arthritis and psoriatic arthritis patients. Arthritis and Rheumatism 57(2): 256-260, 2007

Very Low Disease Activity, DAPSA Remission, and Impact of Disease in a Spanish Population with Psoriatic Arthritis. Journal of Rheumatology 46(7): 710-715, 2019

Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis. Annals of the Rheumatic Diseases 69(8): 1441-1447, 2010

DAPSA and ultrasound show different perspectives of psoriatic arthritis disease activity: results from a 12-month longitudinal observational study in patients starting treatment with biological disease-modifying antirheumatic drugs. Rmd Open 4(2): E000765, 2018

Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score. Annals of the Rheumatic Diseases 75(5): 811-818, 2016

Clinical Characteristics, Disease Activity, and Patient-Reported Outcomes in Psoriatic Arthritis Patients With Dactylitis or Enthesitis: Results From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry. Arthritis Care and Research 69(11): 1692-1699, 2017